Seres Therapeutics Inc (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: October 23, 2018
Pages: 53
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: S8CF60EBDB3EN
Leaflet:

Download PDF Leaflet

Seres Therapeutics Inc (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’s lead development candidate, SER-109 is an oral microbiome therapeutic and bacterial spore ecology that is being developed for the prevention of recurrent clostridium difficile infection in adults. Seres’ SER-287 is an oral therapy for the treatment of ulcerative colitis, an inflammatory bowel disease. The company utilizes its microbiome therapeutics platform to identify key alterations in the microbiome that are associated with or lead to specific diseases. Seres is headquartered in Cambridge, Massachusetts, the US.

Seres Therapeutics Inc (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Seres Health Raises USD48 Million in Series C Venture Financing
Seres Health Raises USD10 Million in Series B Financing
Seres Health Raises US$10.5 Million In Series A Financing Round
Partnerships
Seres Therapeutics to Enter into Partnership Agreement with MD Anderson and Parker Institute
Seres Therapeutics Enters into Agreement with Emulate
Seres Therapeutics Enters into Agreement with Massachusetts General Hospital
Seres Therapeutics Enters into Research Agreement with Mayo Clinic
Seres Therapeutics Enters into Research Agreement with Memorial Sloan Kettering Cancer Center
Seres Therapeutics Enters into Agreement with University of Pennsylvania
Seres Therapeutics Forms Partnership with Research Institute of St. Joseph’s Hamilton
Seres Therapeutics Forms Partnership with Medical University of Graz
Seres Health Enters into Research Agreement with Mayo Clinic
Licensing Agreements
Nestle Health Science Enters into Licensing Agreement with Seres Therapeutics
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research
Equity Offering
Seres Therapeutics Raises USD153.8 Million in IPO
Seres Health Raises USD65 Million in Financing
Seres Therapeutics Inc - Key Competitors
Seres Therapeutics Inc - Key Employees
Seres Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Aug 02, 2018: Seres Therapeutics reports second quarter financial results and provides operational updates
May 09, 2018: Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Updates
Mar 08, 2018: Seres Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
Nov 08, 2017: Seres Therapeutics Reports Third Quarter 2017 Financial Results
Aug 03, 2017: Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
May 04, 2017: Seres Therapeutics Reports First Quarter 2017 Financial Results and Provides Update on Operational Progress
Mar 16, 2017: Seres Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Operational Progress Update
Corporate Communications
Sep 04, 2018: Seres Therapeutics appoints Meryl Zausner as Board Director
Jan 31, 2018: Seres Therapeutics Names Eric D. Shaff to Additional Role of Chief Operating Officer
Jul 10, 2017: Seres Therapeutics Strengthens Board of Directors with Appointment of Willard Dere, M.D., Former Amgen Chief Medical Officer
Clinical Trials
Apr 17, 2018: Seres Therapeutics Presents New Preclinical Data Supporting the Development of Microbiome Therapeutics for Immuno-Oncology at the 2018 American Association for Cancer Research Annual Meeting
Nov 07, 2017: Seres Therapeutics Awarded Grant from CARB-X to Support Development of Microbiome Therapeutic Candidate
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Seres Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Seres Health Raises USD48 Million in Series C Venture Financing
Seres Health Raises USD10 Million in Series B Financing
Seres Health Raises US$10.5 Million In Series A Financing Round
Seres Therapeutics to Enter into Partnership Agreement with MD Anderson and Parker Institute
Seres Therapeutics Enters into Agreement with Emulate
Seres Therapeutics Enters into Agreement with Massachusetts General Hospital
Seres Therapeutics Enters into Research Agreement with Mayo Clinic
Seres Therapeutics Enters into Research Agreement with Memorial Sloan Kettering Cancer Center
Seres Therapeutics Enters into Agreement with University of Pennsylvania
Seres Therapeutics Forms Partnership with Research Institute of St. Joseph’s Hamilton
Seres Therapeutics Forms Partnership with Medical University of Graz
Seres Health Enters into Research Agreement with Mayo Clinic
Nestle Health Science Enters into Licensing Agreement with Seres Therapeutics
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research
Seres Therapeutics Raises USD153.8 Million in IPO
Seres Health Raises USD65 Million in Financing
Seres Therapeutics Inc, Key Competitors
Seres Therapeutics Inc, Key Employees
Seres Therapeutics Inc, Subsidiaries

LIST OF FIGURES

Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Seres Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Skip to top


Ask Your Question

Seres Therapeutics Inc (MCRB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: